CTLA4 and cancer: Cancer cells are known to impair antitumor immunity by affecting the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death 1 (PD-1) axes with the subsequent downregulation of the T cell effector function [7].